The stock of Hims & Hers Health Inc (HIMS) has seen a -8.85% decrease in the past week, with a 3.12% gain in the past month, and a 30.51% flourish in the past quarter. The volatility ratio for the week is 7.18%, and the volatility levels for the past 30 days are at 7.29% for HIMS. The simple moving average for the last 20 days is -8.45% for HIMS’s stock, with a simple moving average of 77.96% for the last 200 days.
Is It Worth Investing in Hims & Hers Health Inc (NYSE: HIMS) Right Now?
Company’s 36-month beta value is 1.07.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HIMS is 150.68M, and currently, short sellers hold a 11.28% ratio of that floaft. The average trading volume of HIMS on July 01, 2024 was 10.00M shares.
HIMS) stock’s latest price update
Hims & Hers Health Inc (NYSE: HIMS)’s stock price has gone rise by 0.85 in comparison to its previous close of 20.02, however, the company has experienced a -8.85% decrease in its stock price over the last five trading days. fool.com reported 2024-06-29 that There are valid points in the short report, but it may present a buying opportunity for long-term investors.
Analysts’ Opinion of HIMS
Many brokerage firms have already submitted their reports for HIMS stocks, with Citigroup repeating the rating for HIMS by listing it as a “Neutral.” The predicted price for HIMS in the upcoming period, according to Citigroup is $20 based on the research report published on May 22, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see HIMS reach a price target of $15, previously predicting the price at $17. The rating they have provided for HIMS stocks is “Hold” according to the report published on April 16th, 2024.
Canaccord Genuity gave a rating of “Buy” to HIMS, setting the target price at $20 in the report published on April 10th of the current year.
HIMS Trading at 18.17% from the 50-Day Moving Average
After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.56% of loss for the given period.
Volatility was left at 7.29%, however, over the last 30 days, the volatility rate increased by 7.18%, as shares sank -0.88% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +62.69% upper at present.
During the last 5 trading sessions, HIMS fell by -8.85%, which changed the moving average for the period of 200-days by +212.54% in comparison to the 20-day moving average, which settled at $22.04. In addition, Hims & Hers Health Inc saw 126.85% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HIMS starting from Okupe Oluyemi, who sale 11,546 shares at the price of $22.21 back on Jun 25 ’24. After this action, Okupe Oluyemi now owns 177,449 shares of Hims & Hers Health Inc, valued at $256,490 using the latest closing price.
Boughton Soleil, the Chief Legal Officer of Hims & Hers Health Inc, sale 2,335 shares at $22.18 during a trade that took place back on Jun 25 ’24, which means that Boughton Soleil is holding 171,479 shares at $51,790 based on the most recent closing price.
Stock Fundamentals for HIMS
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.82 for the gross margin
The net margin for Hims & Hers Health Inc stands at -0.0. The total capital return value is set at -0.05. Equity return is now at value -0.72, with -0.57 for asset returns.
Based on Hims & Hers Health Inc (HIMS), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at 7.76. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -10.5.
Currently, EBITDA for the company is -23.95 million with net debt to EBITDA at 15.04. When we switch over and look at the enterprise to sales, we see a ratio of 4.25. The receivables turnover for the company is 149.79for trailing twelve months and the total asset turnover is 2.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.80.
Conclusion
In a nutshell, Hims & Hers Health Inc (HIMS) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
